• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过不同血液制备方法评估血浆中α-突触核蛋白和神经丝轻链的水平。

Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods.

作者信息

Chang Kuo-Hsuan, Liu Kou-Chen, Lai Chao-Sung, Yang Shieh-Yueh, Chen Chiung-Mei

机构信息

Department of Neurology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.

Department of Electronic Engineering, Artificial Intelligence and Green Technology Research Center, Chang Gung University, Taoyuan, Taiwan.

出版信息

Front Aging Neurosci. 2021 Nov 8;13:759182. doi: 10.3389/fnagi.2021.759182. eCollection 2021.

DOI:10.3389/fnagi.2021.759182
PMID:34858161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8630588/
Abstract

The potential biomarkers of Parkinson's disease are α-synuclein and neurofilament light chain (NFL). However, inconsistent preanalytical preparation of plasma could lead to variations in levels of these biomarkers. Different types of potassium salts of EDTA and different centrifugation temperatures during plasma preparation may affect the results of α-synuclein and NFL measurements. In this study, we prepared plasma from eight patients with Parkinson's disease (PD) and seven healthy controls (HCs) by using di- and tri-potassium (K- and K-) EDTA tubes and recruited a separated cohort with 42 PD patients and 40 HCs for plasma samples prepared from whole blood by centrifugation at room temperature and 4°C, respectively, in K-EDTA tubes. The plasma levels of α-synuclein and NFL in K- and K-EDTA were similar. However, the levels of α-synuclein in the plasma prepared at 4°C (101.57 ± 43.43 fg/ml) were significantly lower compared with those at room temperature (181.23 ± 196.31 fg/ml, < 0.001). Room temperature preparation demonstrated elevated plasma levels of α-synuclein in PD patients (256.6 ± 50.2 fg/ml) compared with the HCs (102.1 ± 0.66 fg/ml, < 0.001), whereas this increase in PD was not present by preparation at 4°C. Both plasma preparations at room temperature and 4°C demonstrated consistent results of NFL, which are increased in PD patients compared with HCs. Our findings confirmed that K- and K-EDTA tubes were interchangeable for analyzing plasma levels of α-synuclein and NFL. Centrifugation at 4°C during plasma preparation generates considerable reduction and variation of α-synuclein level that might hinder the detection of α-synuclein level changes in PD.

摘要

帕金森病的潜在生物标志物是α-突触核蛋白和神经丝轻链(NFL)。然而,血浆分析前准备不一致可能导致这些生物标志物水平的变化。血浆制备过程中不同类型的乙二胺四乙酸(EDTA)钾盐以及不同的离心温度可能会影响α-突触核蛋白和NFL测量结果。在本研究中,我们使用二钾(K-)和三钾(K-)EDTA管从8例帕金森病(PD)患者和7例健康对照(HCs)中制备血浆,并招募了一个单独的队列,其中42例PD患者和40例HCs,分别在K-EDTA管中于室温及4°C下通过全血离心制备血浆样本。K-和K-EDTA中α-突触核蛋白和NFL的血浆水平相似。然而,4°C下制备的血浆中α-突触核蛋白水平(101.57±43.43 fg/ml)与室温下(181.23±196.31 fg/ml,<0.001)相比显著降低。室温制备显示PD患者血浆中α-突触核蛋白水平(256.6±50.2 fg/ml)高于HCs(102.1±0.66 fg/ml,<0.001),而4°C制备时PD患者并未出现这种升高。室温及4°C下的血浆制备均显示NFL结果一致,与HCs相比,PD患者中NFL升高。我们的研究结果证实,K-和K-EDTA管在分析α-突触核蛋白和NFL的血浆水平时可互换。血浆制备过程中在4°C下离心会使α-突触核蛋白水平显著降低并产生变化,这可能会阻碍检测PD中α-突触核蛋白水平的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/7dff1efa30bf/fnagi-13-759182-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/f6f27e33d02b/fnagi-13-759182-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/3245eadab143/fnagi-13-759182-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/ea0c3f341a43/fnagi-13-759182-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/22f4facb19e5/fnagi-13-759182-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/2b89ccb48ae3/fnagi-13-759182-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/7dff1efa30bf/fnagi-13-759182-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/f6f27e33d02b/fnagi-13-759182-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/3245eadab143/fnagi-13-759182-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/ea0c3f341a43/fnagi-13-759182-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/22f4facb19e5/fnagi-13-759182-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/2b89ccb48ae3/fnagi-13-759182-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/8630588/7dff1efa30bf/fnagi-13-759182-g006.jpg

相似文献

1
Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods.通过不同血液制备方法评估血浆中α-突触核蛋白和神经丝轻链的水平。
Front Aging Neurosci. 2021 Nov 8;13:759182. doi: 10.3389/fnagi.2021.759182. eCollection 2021.
2
Plasma Total α-Synuclein and Neurofilament Light Chain: Clinical Validation for Discriminating Parkinson's Disease from Normal Control.血浆总α-突触核蛋白和神经丝轻链:用于鉴别帕金森病与正常对照的临床验证。
Dement Geriatr Cogn Disord. 2020;49(4):401-409. doi: 10.1159/000510325. Epub 2020 Nov 26.
3
Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease.综合血浆和神经影像学生物标志物与帕金森病运动和认知严重程度的相关性。
J Parkinsons Dis. 2020;10(1):77-88. doi: 10.3233/JPD-191766.
4
Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease.帕金森病患者的泪液中 α-突触核蛋白和神经丝轻链水平升高,视网膜微血管密度降低。
Geroscience. 2022 Jun;44(3):1551-1562. doi: 10.1007/s11357-022-00576-6. Epub 2022 Apr 28.
5
Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.多系统萎缩与帕金森病相比脑脊液中神经丝轻链水平的Meta分析
Neurol Sci. 2017 Mar;38(3):407-414. doi: 10.1007/s10072-016-2783-7. Epub 2016 Nov 28.
6
CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls.CSF 或血清神经丝轻链添加到 α-突触核蛋白检测面板可区分帕金森病与对照组。
Mov Disord. 2020 Feb;35(2):288-295. doi: 10.1002/mds.27897. Epub 2019 Nov 18.
7
Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.帕金森病患者血浆细胞外囊泡α-突触核蛋白水平。
Biomolecules. 2021 May 17;11(5):744. doi: 10.3390/biom11050744.
8
Neurofilament light as a biomarker for motor decline in Parkinson's disease.神经丝轻链作为帕金森病运动功能衰退的生物标志物。
Front Neurosci. 2022 Sep 1;16:959261. doi: 10.3389/fnins.2022.959261. eCollection 2022.
9
Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.血浆神经丝轻链作为早期帕金森病姿势不稳步态障碍运动亚型的诊断和预后生物标志物的效用。
Mol Neurodegener. 2020 Jun 5;15(1):33. doi: 10.1186/s13024-020-00385-5.
10
Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson's Disease.血浆磷酸化丝氨酸129α-突触核蛋白是帕金森病运动严重程度和病情进展的替代生物流体标志物。
J Clin Med. 2019 Oct 3;8(10):1601. doi: 10.3390/jcm8101601.

引用本文的文献

1
Eight-Year Longitudinal Study on the Assay Stability of Plasma Amyloid Beta 1-42 Peptide and Total Tau Protein Using Immunomagnetic Reduction.使用免疫磁珠法对血浆β淀粉样蛋白1-42肽和总tau蛋白检测稳定性的八年纵向研究。
Mol Neurobiol. 2025 May 17. doi: 10.1007/s12035-025-05049-3.
2
Alpha-synuclein in peripheral body fluid as a biomarker for Parkinson's disease.外周体液中的α-突触核蛋白作为帕金森病的生物标志物
Acta Neurol Belg. 2024 Jun;124(3):831-842. doi: 10.1007/s13760-023-02452-2. Epub 2024 Jan 3.
3
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson's Disease.

本文引用的文献

1
Blood neurofilament light: a critical review of its application to neurologic disease.血液神经丝轻链:在神经疾病中的应用评价。
Ann Clin Transl Neurol. 2020 Dec;7(12):2508-2523. doi: 10.1002/acn3.51234. Epub 2020 Nov 4.
2
Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease.血浆和血清α-突触核蛋白作为帕金森病患者诊断的生物标志物
Front Neurol. 2020 Jan 21;10:1388. doi: 10.3389/fneur.2019.01388. eCollection 2019.
3
Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein.
血浆中神经酰胺和磷脂代谢途径及精氨酸水平的改变可作为帕金森病的生物标志物。
Cells. 2022 Jan 24;11(3):395. doi: 10.3390/cells11030395.
帕金森病是一种淀粉样变性疾病,其特征是α-突触核蛋白的淀粉样纤维的积累。
Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):17963-17969. doi: 10.1073/pnas.1906124116. Epub 2019 Aug 19.
4
Blood NfL: A biomarker for disease severity and progression in Parkinson disease.血液 NfL:帕金森病疾病严重程度和进展的生物标志物。
Neurology. 2019 Sep 10;93(11):e1104-e1111. doi: 10.1212/WNL.0000000000008088. Epub 2019 Aug 16.
5
Preanalytical sample handling recommendations for Alzheimer's disease plasma biomarkers.阿尔茨海默病血浆生物标志物的分析前样本处理建议
Alzheimers Dement (Amst). 2019 Apr 2;11:291-300. doi: 10.1016/j.dadm.2019.02.002. eCollection 2019 Dec.
6
Plasma alpha-synuclein detected by single molecule array is increased in PD.通过单分子阵列检测到的血浆α-突触核蛋白在 PD 中增加。
Ann Clin Transl Neurol. 2019 Feb 15;6(3):615-619. doi: 10.1002/acn3.729. eCollection 2019 Mar.
7
Optimized plasma preparation is essential to monitor platelet-stored molecules in humans.优化的血浆制备对于监测人类血小板储存分子至关重要。
PLoS One. 2017 Dec 8;12(12):e0188921. doi: 10.1371/journal.pone.0188921. eCollection 2017.
8
Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.家族性阿尔茨海默病中的血清神经丝轻链:早期神经退行性变的标志物。
Neurology. 2017 Nov 21;89(21):2167-2175. doi: 10.1212/WNL.0000000000004667. Epub 2017 Oct 25.
9
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.多发性硬化症患者从注射治疗改为芬戈莫德后血浆神经丝轻链水平。
Mult Scler. 2018 Jul;24(8):1046-1054. doi: 10.1177/1352458517715132. Epub 2017 Jun 19.
10
Plasma α-synuclein predicts cognitive decline in Parkinson's disease.血浆α-突触核蛋白可预测帕金森病的认知衰退。
J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):818-824. doi: 10.1136/jnnp-2016-314857. Epub 2017 May 26.